Literature DB >> 2963867

Immunosuppressive properties of the soluble toxin from Mycobacterium ulcerans.

M Pimsler1, T A Sponsler, W M Meyers.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 2963867     DOI： 10.1093/infdis/157.3.577

Source DB:  PubMed          Journal:  J Infect Dis        ISSN： 0022-1899            Impact factor:   5.226


× No keyword cloud information.
  17 in total

1.  The role of CD4+ lymphocytes in the activation of non-specific suppressor cells by antigen.

Authors:  H Stefanovic; C Izaguirre; L G Filion
Journal:  Immunology       Date:  1989-07       Impact factor: 7.397

Review 2.  Treating Mycobacterium ulcerans disease (Buruli ulcer): from surgery to antibiotics, is the pill mightier than the knife?

Authors:  Paul J Converse; Eric L Nuermberger; Deepak V Almeida; Jacques H Grosset
Journal:  Future Microbiol       Date:  2011-10       Impact factor: 3.165

3.  Mycobacterium ulcerans triggers T-cell immunity followed by local and regional but not systemic immunosuppression.

Authors:  Alexandra G Fraga; Andrea Cruz; Teresa G Martins; Egídio Torrado; Margarida Saraiva; Daniela R Pereira; Wayne M Meyers; Françoise Portaels; Manuel T Silva; António G Castro; Jorge Pedrosa
Journal:  Infect Immun       Date:  2010-10-25       Impact factor: 3.441

4.  Prophylactic effect of mycobacterium bovis BCG vaccination against osteomyelitis in children with Mycobacterium ulcerans disease (Buruli Ulcer).

Authors:  F Portaels; J Aguiar; M Debacker; C Steunou; C Zinsou; A Guédénon; W M Meyers
Journal:  Clin Diagn Lab Immunol       Date:  2002-11

5.  Infection with Mycobacterium ulcerans induces persistent inflammatory responses in mice.

Authors:  Martinha S Oliveira; Alexandra G Fraga; Egídio Torrado; António G Castro; João P Pereira; Adhemar Longatto Filho; Fernanda Milanezi; Fernando C Schmitt; Wayne M Meyers; Françoise Portaels; Manuel T Silva; Jorge Pedrosa
Journal:  Infect Immun       Date:  2005-10       Impact factor: 3.441

6.  Evidence for an intramacrophage growth phase of Mycobacterium ulcerans.

Authors:  Egídio Torrado; Alexandra G Fraga; António G Castro; Pieter Stragier; Wayne M Meyers; Françoise Portaels; Manuel T Silva; Jorge Pedrosa
Journal:  Infect Immun       Date:  2006-12-04       Impact factor: 3.441

7.  Mycobacterium ulcerans cytotoxicity in an adipose cell model.

Authors:  K M Dobos; P L Small; M Deslauriers; F D Quinn; C H King
Journal:  Infect Immun       Date:  2001-11       Impact factor: 3.441

8.  Differentiation of Mycobacterium ulcerans, M. marinum, and M. haemophilum: mapping of their relationships to M. tuberculosis by fatty acid profile analysis, DNA-DNA hybridization, and 16S rRNA gene sequence analysis.

Authors:  T Tønjum; D B Welty; E Jantzen; P L Small
Journal:  J Clin Microbiol       Date:  1998-04       Impact factor: 5.948

9.  Partial purification and characterization of biological effects of a lipid toxin produced by Mycobacterium ulcerans.

Authors:  K M George; L P Barker; D M Welty; P L Small
Journal:  Infect Immun       Date:  1998-02       Impact factor: 3.441

10.  Variability in 3' end of 16S rRNA sequence of Mycobacterium ulcerans is related to geographic origin of isolates.

Authors:  F Portaels; P A Fonteyene; H de Beenhouwer; P de Rijk; A Guédénon; J Hayman; M W Meyers
Journal:  J Clin Microbiol       Date:  1996-04       Impact factor: 5.948
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.